Linsky Amy, Simon Steven R, Stolzmann Kelly, Meterko Mark
*Section of General Internal Medicine, VA Boston Healthcare System, Boston †Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System and ENRM Veterans Affairs Medical Center, Boston and Bedford MA ‡Section of General Internal Medicine, Boston Medical Center, Boston §Performance Measurement, VHA Office of Analytics and Business Intelligence, Bedford ∥Health Law, Policy and Management, Boston University School of Public Health, Boston, MA.
Med Care. 2017 Mar;55(3):306-313. doi: 10.1097/MLR.0000000000000642.
Although clinicians ultimately decide when to discontinue (deprescribe) medications, patients' perspectives may guide the process.
To develop a survey instrument that assesses patients' experience with and attitudes toward deprescribing.
We developed a questionnaire with established and newly created items. We used exploratory factor analysis and confirmatory factor analysis (EFA and CFA) to assess the psychometric properties.
National sample of 1547 Veterans Affairs patients prescribed ≥5 medications.
In the EFA, percent variance, a scree plot, and conceptual coherence determined the number of factors. In the CFA, proposed factor structures were evaluated using standardized root mean square residual, root mean square error of approximation, and comparative fit index.
Respondents (n=790; 51% response rate) were randomly assigned to equal derivation and validation groups. EFA yielded credible 4-factor and 5-factor models. The 4 factors were "Medication Concerns," "Provider Knowledge," "Interest in Stopping Medicines," and "Unimportance of Medicines." The 5-factor model added "Patient Involvement in Decision-Making." In the CFA, a modified 5-factor model, with 2 items with marginal loadings moved based upon conceptual fit, had an standardized root mean square residual of 0.06, an RMSEA of 0.07, and a CFI of 0.91. The new scales demonstrated internal consistency reliability, with Cronbach α's of: Concerns, 0.82; Provider Knowledge, 0.86; Interest, 0.77; Involvement, 0.61; and Unimportance, 0.70.
The Patient Perceptions of Deprescribing questionnaire is a novel, multidimensional instrument to measure patients' attitudes and experiences related to medication discontinuation that can be used to determine how to best involve patients in deprescribing decisions.
尽管临床医生最终决定何时停用(减停)药物,但患者的观点可能会为这一过程提供指导。
开发一种调查工具,以评估患者对减停药物的体验和态度。
我们编制了一份包含既定项目和新创建项目的问卷。我们使用探索性因子分析和验证性因子分析(EFA和CFA)来评估其心理测量特性。
对1547名开具了≥5种药物的退伍军人事务部患者进行全国抽样。
在探索性因子分析中,方差百分比、碎石图和概念连贯性决定了因子数量。在验证性因子分析中,使用标准化均方根残差、近似均方根误差和比较拟合指数来评估所提出的因子结构。
受访者(n = 790;回复率51%)被随机分配到等量的衍生组和验证组。探索性因子分析得出了可靠的四因子和五因子模型。这四个因子分别是“药物相关担忧”、“医生知识”、“停药意愿”和“药物不重要性”。五因子模型增加了“患者参与决策”。在验证性因子分析中,一个经过修改的五因子模型,根据概念拟合移动了两个载荷边际的项目,其标准化均方根残差为0.06,近似均方根误差为0.07,比较拟合指数为0.91。新量表显示出内部一致性信度,克朗巴哈α系数分别为:担忧,0.82;医生知识,0.86;意愿,0.77;参与,0.61;不重要性,0.70。
患者对减停药物的认知问卷是一种新颖的多维度工具,用于测量患者与药物停用相关的态度和体验,可用于确定如何最好地让患者参与减停药物决策。